Orthostatic intolerance is about brain perfusion
The standard tilt table test asks two questions: did heart rate go up enough, and did blood pressure go down enough? These are useful questions. They are not the right questions. Orthostatic intolerance is fundamentally a brain perfusion problem — a failure of adequate blood flow delivery to the brain when a person is upright. Heart rate and blood pressure are peripheral measurements that inform, imperfectly, about cerebral perfusion. A 2019 paper by Norcliffe-Kaufmann in Clinical Autonomic Research makes this argument with data, using transcranial Doppler to measure actual cerebral blood flow velocity during tilt and demonstrating that the brain can be failing to receive adequate blood while the peripheral numbers look unremarkable. The gap between what standard testing measures and what causes orthostatic symptoms is not a theoretical concern. It is something that shows up in the data every time the right measurement is made.
What Standard Tilt Testing Is Actually Measuring
The POTS criterion — heart rate increase of 30 beats per minute or more within 10 minutes of standing — measures whether a specific compensatory response crossed a threshold. The tachycardia in POTS is not the problem. It is the heart's attempt to compensate for inadequate venous return and falling cardiac output, driven by gravitational blood pooling in the lower extremities. The tachycardia threshold tells you whether a particular compensatory pathway was activated strongly enough to cross a defined line. It says nothing directly about whether the compensation worked — whether the brain is actually receiving adequate blood flow despite the cardiovascular challenge.
The orthostatic hypotension criterion — systolic blood pressure falling 20 mmHg or more within three minutes of standing — measures whether peripheral blood pressure dropped to a threshold. Blood pressure at the arm is a measure of systemic pressure, not cerebral perfusion pressure. The brain has its own autoregulatory mechanisms that attempt to maintain cerebral blood flow even when systemic blood pressure varies. Those mechanisms can fail, allowing cerebral blood flow to fall substantially, even when peripheral blood pressure stays above the threshold that triggers an orthostatic hypotension diagnosis. What matters for symptoms is not the pressure in the arm. It is the flow in the brain.
TCD and the Direct Measurement of Cerebral Perfusion
Transcranial Doppler ultrasound measures blood flow velocity in the middle cerebral artery — a major vessel supplying a substantial portion of cerebral blood flow — in real time, continuously, beat by beat. It does this non-invasively by directing ultrasound waves through the temporal bone window and tracking the Doppler shift produced by moving red blood cells. The result is a continuous record of how fast blood is moving through the cerebral circulation during every moment of an orthostatic challenge.
The Norcliffe-Kaufmann 2019 paper uses TCD alongside standard heart rate and blood pressure monitoring during tilt. This dual measurement allows direct comparison of what the standard metrics are showing with what is actually happening in the cerebral circulation at the same moment. In patients with orthostatic intolerance who reported severe symptoms during tilt — dizziness, cognitive difficulty, visual changes, near-syncope — cerebral blood flow velocity was falling substantially while standard vital sign monitoring showed nothing outside normal limits. The brain was being progressively deprived of blood flow. The arm cuff did not see it.
The CO₂ Mechanism: How Standing Changes the Chemical Environment of the Brain
The mechanism connecting upright posture to cerebral hypoperfusion involves not just the mechanical challenge of gravity but the chemical regulation of cerebrovascular tone. CO₂ is the primary chemical regulator of cerebral blood vessel diameter. When CO₂ is in the normal range, cerebral arterioles maintain appropriate tone and blood flow is adequate. When CO₂ falls — hypocapnia — cerebral arterioles constrict directly, reducing cerebral blood flow velocity independently of what heart rate and blood pressure are doing.
In susceptible patients, standing triggers subtle hyperventilation. The respiratory rate increases slightly, CO₂ is blown off faster than it is produced, and arterial CO₂ falls. The brain's cerebrovascular response to this CO₂ reduction is immediate vasoconstriction — a direct chemical effect on smooth muscle in the vessel wall that does not require any change in blood pressure or heart rate to occur. A 10 mmHg drop in CO₂ can reduce cerebral blood flow by 20 to 30 percent. In a patient who is already experiencing reduced venous return and inadequate cardiac output compensation from the gravitational challenge of standing, the additional CO₂-driven vasoconstriction compounds an already-stressed cerebrovascular environment. The two mechanisms act simultaneously, and their effects sum.
The consequence is that two patients can have identical heart rate and blood pressure responses during a tilt test and dramatically different cerebral blood flow outcomes, depending on whether one is subtly hyperventilating and the other is not. Standard monitoring cannot distinguish them because it is not measuring the variable that explains the difference.
The Patient Who Passed Their Tilt Test
A substantial portion of orthostatic intolerance patients do not meet POTS or orthostatic hypotension criteria on standard tilt testing. Their heart rate does not cross the 30 bpm threshold. Their blood pressure does not fall 20 mmHg. By the conventional evaluation framework, they are normal. They are given this result and sent to search for other explanations for their symptoms. Many cycle through specialists. Some are eventually told their symptoms are functional or psychogenic. The institutional conclusion, based on the available data, is that their physiology is not producing the symptoms they report.
The Norcliffe-Kaufmann data establish what is actually happening in a significant proportion of these patients. Their cerebral blood flow is falling during the same tilt test that produced the normal heart rate and blood pressure readings. The measurement that would have identified the problem — cerebral blood flow velocity — was not being taken. The normal tilt result is not a finding of normal orthostatic physiology. It is a finding that the measurements used did not detect an abnormality. Those are not the same statement.
Van Campen and colleagues demonstrated the same pattern in ME/CFS patients — normal vital signs coexisting with 22 to 30 percent cerebral blood flow reductions during tilt — confirming that this is not a feature of any single condition. It is a systematic consequence of using peripheral proxy measurements as substitutes for the direct measurement of cerebral perfusion.
Reframing Orthostatic Intolerance as a Brain Perfusion Problem
The clinical and conceptual reframing the Norcliffe-Kaufmann paper argues for is not subtle. Orthostatic intolerance, across its subtypes — POTS, orthostatic hypotension, HYCH, postural hyperventilation syndrome — is a failure of adequate cerebral blood flow maintenance in the upright posture. The heart rate changes, the blood pressure changes, the CO₂ changes — these are all peripheral manifestations of, or contributors to, that central problem. When they cross diagnostic thresholds, they are useful markers. When they don't, the problem may still be present and only visible with the right measurement.
The diagnostic tools adequate to evaluate orthostatic intolerance as a brain perfusion problem are transcranial Doppler for real-time cerebral blood flow velocity and capnography for continuous CO₂ monitoring. Both are non-invasive. Both are available in clinical settings. TCD has been validated as a standard tool for autonomic laboratory evaluation since 2017, and the evidence connecting CO₂ to cerebral perfusion in orthostatic conditions has been published since 1998. The argument for including them in routine tilt testing is not controversial in the research literature. It simply has not moved into standard practice.
For patients trying to make sense of a normal tilt result that doesn't explain their symptoms, the Norcliffe-Kaufmann paper provides a specific mechanism and a specific measurement that was not performed. The right question after a normal standard tilt is not whether the symptoms are real. It is whether cerebral blood flow was measured during the test. If it was not — and in standard tilt protocols it typically is not — the evaluation did not measure the variable that matters most for the condition being evaluated.